Research

At the core of any scientific progress is knowledge derived from research. FEMERIS supports translational research.

Biomarker Discovery and Diagnostic Test Development

We are applying strategies to discover and evaluate potential biomarkers for use in clinical laboratory testing. We are focused on biomarkers for early detection and evaluation of obstetric and gynecologic infectious diseases and medical conditions from sources such as vaginal, cervical, and uterine swabs, urine and blood.

Drug Target Discovery and High-Throughput Assay Development

We are interested in discovering novel and effective therapies of obstetric and gynecologic infectious diseases and medical conditions.

Probiotic Molecular Engineering

We are interested in developing yeast and bacterial probiotic strains to reduce the inflammation associated with Crohn’s and Irritable Bowel Diseases in the digestive tract. We are also interested in the development of these strains for the purpose of establishing maintaining a healthy vaginal flora for women with recurrent or chronic bacterial vaginosis.

4/2012 - Announcing new testing for Aerobic Vaginitis

4/2012 - Announcing a Complimentary Reflex Test to Determine Metronidazole Resistance in Trichomonas vaginalis

1/2012 - FEMERIS scientist, Dr. David Hilbert, had a manuscript entitled "Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production" accepted into the journal Microbes and Infection.

8/2011 - Announcing new Bacterial Vaginosis/Lactobacillus Profiling Assay

6/2011 - Femeris launches endometriosis research focusing on the discovery of new biomarkers for non-invasive diagnostics and validation of novel therapeutic targets for high-throughput small molecule inhibitor screening.

05/2011 - FEMERIS scientist, Dr. David Hilbert, will be presenting his research on the analysis of host antimicrobial protein production during bacterial vaginosis at the 112th American Society for Microbiology Conference in New Orleans, LA.

04/2011 - FEMERIS scientists will be attending the 2011 American College of Obstetrics and Gynecology conference in Washington D.C.

12/2010 - FEMERIS developed a Urinary Tract Infection Antibiotic Susceptibility assay for the Enterobacteriaceae Escherichia coli, Klebsiella spp., and Proteus mirabilis for Medical Diagnostic Laboratories.

11/2010 - FEMERIS scientist, Dr. Sergey Balashov, presented his research on Neisseria gonorrhoeae antibiotic susceptibility testing at the Association for Molecular Pathology Conference in San Jose, CA.

09/2010 - FEMERIS scientist, Dr. Scott Gygax, presented his research on Methicillin-Resistant Staphylococcus aureus at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy in Boston, MA.